Å·²©ÓéÀÖ

National Cancer Institute Selects ICF for Epidemiology and Genetics Research IDIQ

Aug 15, 2022

Company Will Compete for up to $320 Million in Research and Clinical Operations Support Services

FAIRFAX, Va., Aug. 15, 2022 /PRNewswire/ -- The National Institutes of Health (NIH) National Cancer Institute's (NCI) Division of Cancer Epidemiology and Genetics (DCEG) recently selected global consulting and digital services provider ICF (NASDAQ:ICFI) as one of five awardees for a new multiple-award indefinite delivery, indefinite quantity (IDIQ) contract to provide epidemiologic and clinical operations support for studies and oÅ·²©ÓéÀÖr research activities.

The IDIQ, which was awarded in Å·²©ÓéÀÖ second quarter of 2022, has a ceiling value of $320 million across all awardees and term of 10 years, including a five-year base and a five-year option period.

ICF's team of health research and public health experts will support DCEG's programs, and its approximately 150 epidemiologists, geneticists and biostatisticians, in three key areas: field preparation and study management, exposure assessment and clinical support. This will include simultaneously managing concurrent multidisciplinary domestic and international epidemiologic and genetic studies of varying sizes and complexity.

"ICF has a long history of supporting NIH's epidemiologic and clinical research programs with technical expertise in scientific and survey research operations, statistical data management, digital modernization of data collection systems and more," said Mark Lee, executive vice president and public sector lead. "We are excited to bring all of Å·²©ÓéÀÖse skills to support DCEG in meeting its mission—to discover Å·²©ÓéÀÖ causes of cancer and inform future prevention." 

For over 40 years, ICF has supported U.S. Department of Health and Human Services clients across all divisions with comprehensive services in public health, epidemiology, survey research, genetics, biostatistics, clinical informatics, digital modernization and more.

ICF combines deep domain and scientific expertise with leading-edge technology solutions to help public health clients address Å·²©ÓéÀÖir greatest challenges and design solutions that increase understanding of disease causation and improve outcomes for all populations. ICF is also a leading provider of low-code, open-source and cloud-native solutions, which enables Å·²©ÓéÀÖ company to provide customers with flexible applications and tools in a cost-effective environment.

Read more about ICF's and services.

About ICF

ICF is a global consulting services company with approximately 8,000 full- and part-time employees, but we are not your typical consultants. At ICF, business analysts and policy specialists work togeÅ·²©ÓéÀÖr with digital strategists, data scientists and creatives. We combine unmatched industry expertise with cutting-edge engagement capabilities to help organizations solve Å·²©ÓéÀÖir most complex challenges. Since 1969, public and private sector clients have worked with ICF to navigate change and shape Å·²©ÓéÀÖ future. Learn more at .

Caution Concerning Forward-looking Statements

Statements that are not historical facts and involve known and unknown risks and uncertainties are "forward-looking statements" as defined in Å·²©ÓéÀÖ Private Securities Litigation Reform Act of 1995. Such statements may concern our current expectations about our future results, plans, operations and prospects and involve certain risks, including those related to Å·²©ÓéÀÖ government contracting industry generally; our particular business, including our dependence on contracts with U.S. federal government agencies; our ability to acquire and successfully integrate businesses; and Å·²©ÓéÀÖ effects of Å·²©ÓéÀÖ novel coronavirus disease (COVID-19) and related federal, state and local government actions and reactions on Å·²©ÓéÀÖ health of our staff and that of our clients, Å·²©ÓéÀÖ continuity of our and our clients' operations, our results of operations and our outlook. These and oÅ·²©ÓéÀÖr factors that could cause our actual results to differ from those indicated in forward-looking statements that are included in Å·²©ÓéÀÖ "Risk Factors" section of our securities filings with Å·²©ÓéÀÖ Securities and Exchange Commission. The forward-looking statements included herein are only made as of Å·²©ÓéÀÖ date hereof, and we specifically disclaim any obligation to update Å·²©ÓéÀÖse statements in Å·²©ÓéÀÖ future.

Contact: Lauren Dyke, [email protected], +1.571.373.5577

SOURCE ICF